Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The Trial The ATTAIN-MAINTAIN trial enrolled patients who had achieved substantial weight loss that had plateaued while taking weekly injectable GLP-1s in the SURMOUNT-5 trial
Learn more Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist
[DOI] [PMC free article] [PubMed] [Google Scholar] 138.Wharton S., Batterham R.L., Bhatta M., Buscemi S., Christensen L.N., Frias J.P., Jodar E., Kandler K., Rigas G., Wadden T.A., et al
These supplements support the process but do not replace the medication is core effects
Appetite & Weight Management GLP-1s help naturally reduce hunger and increase satiety, making it easier to enjoy smaller portions and avoid overeating
US$ 29.30
US$ 29.64
US$ 27.54
US$ 20.44
US$ 23.47
US$ 21.14
US$ 27.97
